Chemoinformaics analysis of Gallic Acid (3, 4, 5-Trihydroxybenzoic)
| Molecular Weight | 350.279 | nRot | 3 |
| Heavy Atom Molecular Weight | 336.167 | nRig | 8 |
| Exact Molecular Weight | 350.064 | nRing | 2 |
| Solubility: LogS | -1.118 | nHRing | 0 |
| Solubility: LogP | 1.43 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 2 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 12 |
| nHA | 7 | APOL | 43.2731 |
| nHD | 7 | BPOL | 15.7809 |
| QED | 0.472 |
| Synth | 2.035 |
| Natural Product Likeliness | 1.124 |
| NR-PPAR-gamma | 0.072 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.024 |
| HIA | 0.009 |
| CACO-2 | -5.22 |
| MDCK | 0.000011 |
| BBB | 0.119 |
| PPB | 0.877049 |
| VDSS | 0.37 |
| FU | 0.110721 |
| CYP1A2-inh | 0.048 |
| CYP1A2-sub | 0.069 |
| CYP2c19-inh | 0.036 |
| CYP2c19-sub | 0.046 |
| CYP2c9-inh | 0.27 |
| CYP2c9-sub | 0.231 |
| CYP2d6-inh | 0.014 |
| CYP2d6-sub | 0.164 |
| CYP3a4-inh | 0.043 |
| CYP3a4-sub | 0.038 |
| CL | 10.973 |
| T12 | 0.93 |
| hERG | 0.018 |
| Ames | 0.183 |
| ROA | 0.833 |
| SkinSen | 0.942 |
| Carcinogencity | 0.233 |
| EI | 0.972 |
| Respiratory | 0.422 |
| NR-Aromatase | 0.013 |
| Antiviral | Yes |
| Prediction | 0.547213 |